Glaucoma in perspective

New technologies and collaborative care are improving the quality of life of patients with glaucoma

Glaucoma is one of the leading causes of irreversible blindness in the world, estimated to affect 66 million people worldwide and some 300 000 Australians.1,2 The majority of glaucoma patients present with progressive asymptomatic visual loss, with over 50% remaining undiagnosed.3 Annual costs of glaucoma to the health system in Australia are estimated to increase from $355 million in 2005 to $784 million by 2025.2 Management of this disease requires early detection, encouraging treatment adherence, improving patients’ quality of life and advancing medical research. To achieve this, strong collaboration is required between ophthalmologists, optometrists, orthoptists, pharmacists, general practitioners, patient advocacy groups like Glaucoma Australia and the Royal Australian and New Zealand College of Ophthalmologists, and funding bodies.